A recent analysis from Pantera Capital, a prominent cryptocurrency investment firm, highlights the significant upside potential for Solana (SOL), a layer-1 blockchain utility token. The report underscores that institutional investors are currently underexposed to Solana compared to leading cryptocurrencies, Bitcoin (BTC) and Ethereum (ETH). Presently, institutional holdings of Solana account for less than 1% of its total supply, while BTC and ETH see allocations of 16% and 7%, respectively.
Pantera Capital suggests that Solana is poised for its “institutional moment” in light of the anticipated approval of a spot Solana exchange-traded fund (ETF) in the upcoming fourth quarter of 2025. The firm points to the successful launch of Bitcoin and Ethereum ETFs as pivotal moments that accelerated institutional adoption within the space. They noted the existence of 43 Bitcoin ETFs and 21 Ethereum ETFs, alongside 165 public companies holding Bitcoin and 16 companies holding Ethereum. In stark contrast, Solana has yet to see any ETFs launched and is held by only five public companies.
The firm also cites increasing interest from established companies, including blue-chip firms such as PayPal and Stripe, which are beginning to build on the Solana blockchain. Despite Solana’s higher usage metrics relative to Bitcoin and Ethereum, its market capitalization remains significantly lower—approximately a quarter of Ethereum’s value and 1/20th that of Bitcoin’s.
In a related development, Helius Medical Technologies, a company backed by Pantera Capital, has raised over $500 million with the intent to acquire Solana. This move indicates confidence in Solana as a primary asset within its treasury.
As of the latest reports, Solana’s value stands at $238, showcasing its position in the cryptocurrency market amid evolving institutional interest. This trend could potentially set the stage for further growth and mainstream adoption of the token in the near future.
